The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...
The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
The head of the US Food and Drug Administration department responsible for assuring the safety and effectiveness of vaccines ...
Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results